Post de adMare BioInnovations

Countdown: Only 5 days to go! 🚀 I'm eagerly looking forward to our session 📢 “Animal Model Alternatives: The Future of Drug Screening is Driven by Human Biology“ 📢 at the AusBiotech Conference 2023 in #Brisbane. I've had the privilege to organize this pivotal discussion, and the anticipation is mounting. Steering the conversation will be Dr Tam C. Nguyen from St Vincent's Hospital Melbourne. Our topic couldn't be timelier, especially with the insights from CSIRO’s recent Non-Animal Models report [https://lnkd.in/gWUDyWvZ], spotlighting a $1.5 billion opportunity for #Australia. Thrilled to share the panel with a lineup of industry experts: 🔹Greg Williams, the driving force behind the CSIRO Futures report, and 🔹Natalie Anderson of Humane Research Australia 🔹Amanda Richman from Australian Ethical Investment 🔹Dr. Chris Schyvens from the Therapeutic Goods Administration The tides of preclinical drug development are shifting. Melded with regulatory shifts and #ESG dynamics, we're witnessing a paradigm change. Don't miss out on this conversation at #AusBio23! Do check out more about the AusBiotech Conference 2023 here: https://lnkd.in/gA3sfwkc Let's champion #Innovation, #Biotechnology, and the future of #DrugDevelopment. See you there! Tessara Therapeutics Lorraine Chiroiu #Neuroscience #TissueEngineering #Australia #Team #SuccessStory #AlzheimersDisease #NAMs #NonAnimalModels

🚀 Exciting Announcement at JPM Healthcare Conference! 🌐 We are thrilled to share that at the JPM Healthcare Conference on January 9th, Dong-A ST and Eleven Therapeutics inked a Memorandum of Understanding (MoU). Under this MOU, the companies will focus on developing RNA-based therapies for fibrotic diseases using Eleven’s high throughput screening platform, TERÅ®, which is used to find the most suitable non-canonical elements in therapeutic xRNA molecules. We are excited to put together this collaboration with Dong-A ST and expand our R&D efforts to tackle unmet medical needs in fibrotic disorders. Dong-A ST’s team brings a wealth of experience in this therapeutic area, complementing Eleven’s prowess in next generation mRNAs. This partnership can allow us to expand into new markets, and adds to our growing set of collaborations, ultimately aimed to accelerate the translation of our groundbreaking xRNA modality into a solution for a multitude of devastating ailments. Read more: https://shorturl.at/cpERV #11TX #HealthcareInnovation #GeneTherapy #Biotechnology #Partnership #MedicalResearch #JPMHealthcareConference #FibrosisTreatment 💊

Global collaborations with Pharmaceutical leaders serve to amplify our own pipeline and fulfill Eleven Therapeutics' mission to translate our xRNA modality into impactful medicines. The MOU signed last week with Dong-A ST (see below), under the championship of Jaehong Park, president and CSO, is a springboard to exploring the ways that xRNA, empowered by TERA, can accelerate R&D of #FibroticDisorder medicines. What a great way to kick start 2024!

Massive Bio's Impact in Germany and Poland: Advancing Healthcare Innovation 🌍 Global Progress: Exciting news from Massive Bio! We're making significant strides in Germany and Poland, with our team engaging key healthcare players at the Health Tech Forward conference in Poland. Special thanks to our leaders Arturo LoAIza-Bonilla MD and Toygun Onaran for representing us brilliantly. 🇩🇪 German Ventures: Our co-founder Çağatay M. Çulcuoğlu leads our expansion across Germany, fostering partnerships in cities like Stuttgart and Berlin. Check out our feature in Kilim newspaper for insights on our journey in Germany. Read more: https://lnkd.in/dmVNx_wJ 🇵🇱 Polish Collaborations: In Poland, engaging with the National Oncology Institute and others has been pivotal in discussing advancements in oncology and AI, driving our mission to enhance cancer care. 🔜 The Road Ahead: These ventures mark just the beginning of our journey in transforming global healthcare. We're thrilled to advance these collaborations and make a lasting impact. Selin Kurnaz, PhD, Arturo LoAIza-Bonilla MD, Çağatay M. Çulcuoğlu, Toygun Onaran, Marta Halke-Markiewicz, Ali Batmaz, Kilim Gazetesi #MassiveBio #HealthTech #Germany #Poland #OncologyInnovation #AIHealthcare

🎈 The first and only ATMP centre for children in the Nordic countries has been opened at Sahlgrenska University Hospital in Gothenburg! 🎈 ATMP covers medicines based on genes, cells and tissues. These new biological medicines have the potential to revolutionise healthcare with personalised treatments for diseases such as cancer, diabetes and cardiovascular diseases - and even rare genetic diseases that have previously been incurable. The Gothenburg region has many strengths in ATMP, not least through AstraZeneca, which has a strong focus on regenerative care and ATMP. A number of niche start-ups across the spectrum of possibilities make developments even more exciting, including Cellink, Fluicell and Elicera therapeutics. In addition, a major national centre, CCRM Nordic, is now being built in Gothenburg for the rapid commercialisation of ATMP. There, innovators will be able to collaborate with researchers from companies such as AstraZeneca, CombiGene, Cytiva, Getinge, Takara Bio Europe, TATAA Biocenter and Verigraft.  Read more about Gothenburg's strengths in ATMP: https://lnkd.in/d3AGgwJj #gothenburg #lifescience #ATMP

This week is buzzing with three incredible conferences happening simultaneously and I am on my way to two of them, bringing my son to experience the impact of healthcare innovation in our life!!! 1. CX Healthcare in Carlsbad, CA: Focusing on the latest trends and innovations in patient experience and healthcare delivery. It's a fantastic opportunity to learn how we can better serve our patients and improve the overall healthcare journey. 2. BIO International Convention in San Diego, CA: The premier event for the biotechnology industry, bringing together industry leaders, researchers, and investors to discuss breakthroughs in biotech and life sciences. It's a great platform for fostering innovation and collaboration. 3. ASCO Annual Meeting in Chicago, IL: The go-to event for oncology professionals worldwide. It's all about advancing cancer care, sharing cutting-edge research, and improving patient outcomes through scientific excellence. Each of these conferences is vital in its own way, contributing to the betterment of healthcare, scientific progress, and patient care. The convergence of these events highlights the dynamic and interconnected nature of our industry. Let's seize these opportunities to learn, network, and drive meaningful change! 🚀 #Healthcare #Biotech #Oncology #Innovation #PatientCare

🌍 Today is World Health Day, a global observance dedicated to recognizing health as a fundamental human right, promoting equitable access to quality healthcare around the world, and advocating for investment in innovation and research. At NANOGAP, we stand in solidarity with this mission, committed to advancing innovative technologies that improve people's well-being and provide therapeutic solutions. Through our spin-off company, ARJUNA Therapeutics, we harness the power of metal molecules to open new therapeutic avenues, especially in the fight against incurable cancers. Arjuna's innovative therapeutic molecular clusters (TMCs) represent a paradigm shift in drug development, targeting critical vulnerabilities to fight diseases more effectively. 🔬 In parallel, NANOGAP is working on the development of a rapid diagnostic kit for pneumonia. In collaboration with a Technology Incubator consortium, we aim to revolutionize pneumonia diagnosis, ensuring timely and accurate detection to improve patient outcomes. On this World Health Day, let us reaffirm our commitment to advancing health innovation and fostering a world where everyone can access the care they need. Together we can build a healthier and more resilient future for all 💯

We're live at the heart of innovation on the third day of #BIOEurope in Munich! Embarking on this journey has been nothing short of inspiring—immerse yourself in a sea of insights, forge valuable connections, and engage in conversations that spark transformation. Representing PDC Therapeutics, it's an honor to contribute to the dynamic ecosystem at #BIOEurope2023, where every handshake has the potential to become a milestone in new treatments. The passion is palpable in Munich! The drive for advancements in nanomedicine is a shared goal, and the optimism for groundbreaking collaborations is in the air—collaborations that could redefine the future of therapies. Join us at the SWISS BIOTECH Pavilion, where our commitment to innovative drug discovery fuels our quest for the next frontier in cancer treatment. With our platform technology and a relentless spirit, we're not just envisioning the future of therapies; we're actively shaping it with no compromises. Let's connect and explore how together, we can turn today's possibilities into tomorrow's breakthroughs! w/ Prof. Rana Sanyal, PhD | Sena Nomak | Gülşah Nomak, MD   w/ Swiss Biotech Association | Switzerland Global Enterprise | EBD Group | Biopôle Lausanne #PDCTherapeutics #CancerResearch #DrugDiscovery #Innovation #Collaboration #FutureOfHealthcare #SwissPavilion #SwissBiotech #DrugDelivery #TherapiesWithNoCompromise  

High summer temperatures do not hinder our community of #ImpactMakers to keep moving forward ☀ ✅ ADmit Therapeutics appoints Dr. Russell Swerdlow to its Scientific Advisory Board. ✅ The Journal Actas Urológicas Españolas has published the results of Devicare's #Canoxidin to prevent urinary tract infections performing 10x better than the placebo group. ✅ Fiction Express Education is present in 3 out of 4 Spanish-speaking countries and is already used by 1M students. NTN24 echoes its methodology by interviewing its co-founder, Cristina Puig. ✅ IMA Ibérica Asistencia partners with KOMOBI to speed up motorcyclist emergencies. ✅ Lura Care has been named Best Inernational Mobile Health Services Provider in Europe 2024 by Global Health & Pharma Magazine ✅ Mika partners with AstraZeneca and Daiichi Sankyo Europe GmbH to provide digital therapeutics to women undergoing breast cancer treatments. ✅ Ocean Ecostructures closes a €500K deal with AVANÇSA to consolidate its strategic plan and continue scaling up its project. ✅ Sycai Medical, winner of the #SouthSummit24 health category. Thanks for leading the #impact revolution 🚀 #ImpactInvesting